Insights into the self-assembly and interaction of sars-cov-2 fusion peptides with biomimetic plasma membranes.

Insights into the self-assembly and interaction of sars-cov-2 fusion peptides with biomimetic plasma membranes.

Publication date: Dec 20, 2025

First identified in late 2019, the COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, rapidly escalated into a global health crisis. SARS-CoV-2 is a single-stranded RNA virus encased in a lipid envelope that houses key structural proteins, including the Spike glycoprotein, which mediates viral entry into host cells. Within Spike, the S2 subunit, and particularly its fusion domain, plays a critical role in merging viral and host membranes. To explore how receptor-driven Spike clustering influences this process, we investigated the self-assembly of S2 fusion peptides (FPs) and their interactions with biomimetic plasma membrane (PM) models composed of phospholipids, sphingomyelin, and cholesterol. Atomic force microscopy, laser direct infrared spectroscopy, neutron reflectometry, and grazing-incidence X-ray diffraction reveal that FPs form supramolecular assemblies that exclude cholesterol-rich nanodomains, increase membrane fluidity, and disrupt raft-like order associated with ACE2 binding. The appearance of spiral FP fibers supports a loaded-spring mechanism for membrane remodeling, offering a model for cooperative peptide-driven fusion, highlighting opportunities for antiviral and nanobiotechnological applications.

Open Access PDF

Concepts Keywords
Coronavirus Assembly
Nanobiotechnological Biomimetic
Remodeling Cholesterol
Rich Cov
Driven
Fusion
Host
Membrane
Membranes
Peptides
Plasma
Sars
Self
Spike
Viral

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Omega-3 fatty acids
drug DRUGBANK Cholesterol
pathway REACTOME Reproduction
disease MESH included
drug DRUGBANK Diethylstilbestrol
disease MESH des
disease MESH viral infection
drug DRUGBANK Proline
pathway KEGG Virion
drug DRUGBANK Medical air
drug DRUGBANK Water
drug DRUGBANK L-Phenylalanine
drug DRUGBANK L-Leucine
drug DRUGBANK L-Lysine
drug DRUGBANK L-Arginine
drug DRUGBANK L-Cysteine
drug DRUGBANK Barium
drug DRUGBANK Isoxaflutole
drug DRUGBANK L-Isoleucine
drug DRUGBANK L-Valine
drug DRUGBANK L-Aspartic Acid
drug DRUGBANK Tricyclazole
drug DRUGBANK Glycine
drug DRUGBANK Albendazole
drug DRUGBANK Dimethyl sulfoxide
drug DRUGBANK Phosphatidylethanolamine
drug DRUGBANK Phosphatidyl serine
drug DRUGBANK Ethanol
drug DRUGBANK Oxygen
drug DRUGBANK Silicon
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Carboxyamidotriazole
drug DRUGBANK Angiotensin II
drug DRUGBANK Nonoxynol-9
drug DRUGBANK Guanosine
disease MESH AEI

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *